| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $266K | -37.0% | — |
| Cost of Revenue | $53K | -65.1% | — |
| Gross Profit | $213K | -21.1% | — |
| R&D Expense | $1.7M | +18.2% | +2.1% |
| SG&A Expense | $1.7M | +13.5% | +46.7% |
| Operating Income | -$3.2M | -19.5% | -13.2% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.0M | -18.4% | +5.0% |
| Accounts Receivable | $169K | -53.4% | — |
| Inventory | $272K | — | — |
| Current Assets | $11.0M | -18.0% | — |
| Total Assets | $11.2M | -17.9% | +11.7% |
| Current Liabilities | $1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | — |
| Capital Expenditures | $2K | — | — |
| Investing Cash Flow | -$2K | — | — |
| Financing Cash Flow | $10.8M | — | — |
| Free Cash Flow | -$8.0M | — | — |
| — |
| Net Income | -$2.9M | -0.6% | -17.8% |
| EPS (Basic) | -$0.08 | +0.0% | +20.0% |
| EPS (Diluted) | -$0.08 | +0.0% | +20.0% |
| +21.1% |
| +6.3% |
| Total Liabilities | $3.1M | +4.2% | +5.7% |
| Stockholders' Equity | $8.1M | -24.1% | +14.2% |